Arkema Sa Adr Stock Performance
| ARKAY Stock | USD 79.24 1.06 1.36% |
The firm shows a Beta (market volatility) of 0.96, which signifies possible diversification benefits within a given portfolio. Arkema SA returns are very sensitive to returns on the market. As the market goes up or down, Arkema SA is expected to follow. At this point, Arkema SA ADR has a negative expected return of -0.21%. Please make sure to confirm Arkema SA's maximum drawdown, as well as the relationship between the accumulation distribution and market facilitation index , to decide if Arkema SA ADR performance from the past will be repeated at some point in the near future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days Arkema SA ADR has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fragile performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long term up-swing for the company investors. ...more
| Begin Period Cash Flow | 1.6 B | |
| Total Cashflows From Investing Activities | 473 M |
Arkema |
Arkema SA Relative Risk vs. Return Landscape
If you would invest 9,134 in Arkema SA ADR on September 1, 2024 and sell it today you would lose (1,210) from holding Arkema SA ADR or give up 13.25% of portfolio value over 90 days. Arkema SA ADR is currently producing negative expected returns and takes up 1.9918% volatility of returns over 90 trading days. Put another way, 17% of traded pink sheets are less volatile than Arkema, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days. Expected Return |
| Risk |
Arkema SA Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Arkema SA's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Arkema SA ADR, and traders can use it to determine the average amount a Arkema SA's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1033
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | ARKAY |
Estimated Market Risk
| 1.99 actual daily | 17 83% of assets are more volatile |
Expected Return
| -0.21 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.1 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Arkema SA is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Arkema SA by adding Arkema SA to a well-diversified portfolio.
Arkema SA Fundamentals Growth
Arkema Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Arkema SA, and Arkema SA fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Arkema Pink Sheet performance.
| Return On Equity | 0.15 | |||
| Return On Asset | 0.0333 | |||
| Profit Margin | 0.09 % | |||
| Operating Margin | 0.06 % | |||
| Current Valuation | 8.73 B | |||
| Shares Outstanding | 74.81 M | |||
| Price To Earning | 18.63 X | |||
| Price To Book | 0.82 X | |||
| Price To Sales | 0.58 X | |||
| Revenue | 9.52 B | |||
| EBITDA | 2.54 B | |||
| Cash And Equivalents | 1.34 B | |||
| Cash Per Share | 18.14 X | |||
| Total Debt | 2.56 B | |||
| Debt To Equity | 0.47 % | |||
| Book Value Per Share | 105.12 X | |||
| Cash Flow From Operations | 915 M | |||
| Earnings Per Share | 15.24 X | |||
| Total Asset | 12.3 B | |||
| Retained Earnings | 1.21 B | |||
| Current Asset | 3.4 B | |||
| Current Liabilities | 1.48 B | |||
About Arkema SA Performance
Evaluating Arkema SA's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Arkema SA has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Arkema SA has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
Arkema S.A. manufactures and sells specialty chemicals and advanced materials worldwide. Arkema S.A. was incorporated in 2003 and is headquartered in Colombes, France. Arkema ADR operates under Specialty Chemicals classification in the United States and is traded on OTC Exchange. It employs 19441 people.Things to note about Arkema SA ADR performance evaluation
Checking the ongoing alerts about Arkema SA for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Arkema SA ADR help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Arkema SA ADR generated a negative expected return over the last 90 days |
- Analyzing Arkema SA's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Arkema SA's stock is overvalued or undervalued compared to its peers.
- Examining Arkema SA's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Arkema SA's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Arkema SA's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Arkema SA's pink sheet. These opinions can provide insight into Arkema SA's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Arkema Pink Sheet Analysis
When running Arkema SA's price analysis, check to measure Arkema SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Arkema SA is operating at the current time. Most of Arkema SA's value examination focuses on studying past and present price action to predict the probability of Arkema SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Arkema SA's price. Additionally, you may evaluate how the addition of Arkema SA to your portfolios can decrease your overall portfolio volatility.